Gold Standard
Regenerative
Stem cell therapy targets the immune imbalance at the root of autoimmune disease, without shutting down your entire immune system the way conventional drugs do.
Autoimmune disease happens when your immune system mistakes your own tissue for a threat and attacks it. The damage depends on which tissue gets hit: joints in rheumatoid arthritis, nerve myelin in multiple sclerosis, the thyroid in Hashimoto's, the pancreas in Type 1 diabetes, or many organs at once in lupus. Stem cell therapy offers a different strategy than the immunosuppressants most patients rely on: instead of shutting the immune system down, stem cells aim to retrain it.
Mesenchymal stem cells (MSCs) are immune-modulating cells that send signals to rebalance an overactive immune response. Once infused, stem cells migrate to sites of inflammation, release regulatory factors that calm destructive immune cells, and help restore normal immune function. Stem cell therapy for autoimmune conditions does not broadly suppress immunity; it works alongside your existing medications to target the root immune dysfunction driving the disease.
Standard treatments like DMARDs, biologic drugs, and corticosteroids reduce inflammation by suppressing the immune system broadly. They help, but come with infection risk, organ stress over the long term, and no path to resetting the underlying dysfunction. Stem cell therapy is a complementary regenerative approach focused on recalibrating the immune system rather than silencing it.
Research supports stem cell therapy and exosomes for several autoimmune conditions. Treatment approaches are tailored to each condition.
Rheumatoid arthritis causes immune-driven joint inflammation and progressive joint damage. Stem cells travel to inflamed joint tissue, reduce the inflammatory signals driving the disease, and boost immune regulators that help protect cartilage and bone.
Lupus involves out-of-control immune activation that can affect many organ systems at once. Stem cell signaling has been shown to restore immune balance, reduce harmful autoantibodies, and calm inflammation across affected organs. Early clinical studies of stem cell therapy show reductions in disease activity scores.
Fibromyalgia and chronic inflammatory fatigue involve heightened nerve sensitivity, brain inflammation, and ongoing immune activation. Exosome-based therapies deliver anti-inflammatory signals that help calm these processes, offering a targeted approach where standard treatments often fall short.
Ankylosing spondylitis causes long-term inflammation in the spine and sacroiliac joints, which can lead to the joints fusing together over time. Stem cell protocols aim to reduce this spinal inflammation, slow structural damage, and help you move better.
A personalized plan built around a thorough assessment of your condition, disease activity, and goals.
We review your diagnosis, disease history, lab results including inflammatory markers, and current medications. This baseline helps us measure your disease activity and identify the best regenerative approach for your condition.
Based on your assessment, we design a customized plan using stem cell therapy, exosome therapy, or a combination. The plan takes into account your condition, current disease activity, how you have responded to past treatments, and which parts of the immune system are most involved.
Depending on your condition, stem cell therapy is delivered by IV infusion for systemic conditions or by targeted injection for joint and spinal disease. Both are outpatient procedures. All stem cell and exosome preparations come from screened, certified providers.
We track your progress using repeat lab tests, disease activity scores, and how you feel day to day over a 3 to 6 month follow-up period. We encourage ongoing coordination with your existing rheumatologist or specialist throughout this time.
Immune rebalancing after stem cell therapy happens gradually. This timeline reflects what most patients experience based on clinical observations and published research.
Stem cells and exosomes begin shifting the body's inflammatory balance. Some patients notice early reductions in joint pain, fatigue, or other symptoms as inflammatory signals start to decrease.
Lab tests often show measurable decreases in inflammation during this period. Disease activity scores begin to improve, and patients often report fewer flare-ups and better tolerance for daily activities.
The immune system continues to rebalance. Functional gains, including better mobility, less pain, and improved energy, typically become most noticeable during this phase.
For those who respond well, benefits hold and may keep improving. Some patients are able to reduce their medication load in coordination with their doctor. This is one of the main goals of the regenerative approach.
Talk with our clinical team to find out if stem cell therapy is right for your autoimmune condition and goals.
CHECK IF YOU QUALIFY →